Zobrazeno 1 - 10
of 12
pro vyhledávání: '"Alane Drexler"'
Autor:
Mary Kathryn Duncan, Alane Drexler, Marcie J. Hursting, Robert Levine, Jamie M. Walker, John L. Francis
Publikováno v:
The American Journal of Emergency Medicine. 25:279-284
Background Patients with heparin–platelet factor 4 (PF4) antibodies, particularly platelet-activating ones, are at risk for heparin-induced thrombocytopenia if administered heparin. We determined the heparin-PF4 antibody prevalence in emergency dep
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6ffa22ff0e45680de28a0a3425f9246d
https://doi.org/10.1016/j.ajem.2006.07.015
https://doi.org/10.1016/j.ajem.2006.07.015
Publikováno v:
Annals of Emergency Medicine. 44:511-515
We describe 3 patients who presented to the emergency department (ED) with stroke, deep venous thrombosis, or pulmonary embolism and renal failure after undergoing cardiac surgery 7 to 17 days earlier. Their onset of thrombosis after previous heparin
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5827055a688d04a31c392e23710525fe
https://doi.org/10.1016/j.annemergmed.2004.06.004
https://doi.org/10.1016/j.annemergmed.2004.06.004
Publikováno v:
The Annals of Thoracic Surgery. 75:17-22
Background Heparin-induced thrombocytopenia (HIT) is a potentially devastating complication of heparin therapy. The incidence of clinical HIT after cardiovascular surgery is less than 2%, although asymptomatic antibodies to heparin-platelet factor 4
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::11f509f10ee799de5124d1526e48df4a
https://doi.org/10.1016/s0003-4975(02)04349-7
https://doi.org/10.1016/s0003-4975(02)04349-7
Autor:
John L. Francis, Alane Drexler
Publikováno v:
Nursing. 36
This immune reaction to a common anticoagulant can have devastating consequences. Learn how to recognize who's at risk and how to intervene if trouble hits.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c7dac07c0dc6716531fe68967ab50fae
https://pubmed.ncbi.nlm.nih.gov/16641686
https://pubmed.ncbi.nlm.nih.gov/16641686
Autor:
Mildred Amaya, Kristin Rathmann, Ali Amirkhosravi, Eduardo Reyes, John L. Francis, Hina Desai, Todd Meyer, Glenn Bigsby, John Barranco, Alane Drexler, Meghan Hatfield
Publikováno v:
Blood Coagulation & Fibrinolysis. 23:176-177
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8e9f4305cb6951cb31727df7b30a41d2
https://doi.org/10.1097/mbc.0b013e32834eb972
https://doi.org/10.1097/mbc.0b013e32834eb972
Autor:
Ali Amirkhosravi, Alane Drexler, Edward Reyes, Hina Desai, John L. Francis, Mary Kathryn Duncan, Theresa Robson, Mildred Amaya, Kristin Rathmann, Todd Meyer
Publikováno v:
Blood. 108:1051-1051
The laboratory diagnosis of heparin-induced thrombocytopenia (HIT) relies on the demonstration of antibodies to the heparin-platelet factor 4 (H-PF4) complex. Assays are based on the functional ability of H-PF4 antibodies to activate platelets, or de
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8b8fffa541fcec6d6c66fbef4d6d3529
https://doi.org/10.1182/blood.v108.11.1051.1051
https://doi.org/10.1182/blood.v108.11.1051.1051
Autor:
John L. Francis, Alane Drexler, Patricia Faust, Liza Robles, Mildred Amaya, Ali Amirkhosravi, Florian Länger, Edward Reyes, Glenn Bigsby, Hina Desai, Enriqueta Coll
Publikováno v:
Blood. 108:1762-1762
Coagulation and platelet activation occurs in patients with ovarian cancer, and several factors underlying such hypercoagulability have been implicated in tumor growth and metastasis. The incidence of venous thromboembolism throughout the course of o
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b4d39d2b0e447cdf53671dccc20857d9
https://doi.org/10.1182/blood.v108.11.1762.1762
https://doi.org/10.1182/blood.v108.11.1762.1762
Publikováno v:
Blood. 104:3951-3951
Heparin-induced thrombocytopenia occurs in approximately 1–3% of patients receiving unfractionated heparin. However, up to 50% of patients receiving heparin for systemic anticoagulation during cardiac surgery with cardiopulmonary bypass develop ant
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7a53f25700aef76f60eb962bde9ec736
https://doi.org/10.1182/blood.v104.11.3951.3951
https://doi.org/10.1182/blood.v104.11.3951.3951
Publikováno v:
Blood. 104:2067-2067
Heparin is widely used to treat patients that present with acute coronary syndromes (ACS). A significant, albeit under-recognized complication of heparin therapy is heparin-induced thrombocytopenia (HIT), which is estimated to occur in 1–3% of pati
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3f0d3a0877ecd3a12c18355bebe594ad
https://doi.org/10.1182/blood.v104.11.2067.2067
https://doi.org/10.1182/blood.v104.11.2067.2067
Publikováno v:
Blood. 104:4077-4077
Heparin-induced thrombocytopenia (HIT) is a serious complication of heparin therapy. As thrombosis occurs in 50% of untreated patients, prompt treatment with a direct thrombin inhibitor (DTI) is recommended. Lepirudin and argatroban are currently app
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::65e340646defe0ab6394172b147b8f86
https://doi.org/10.1182/blood.v104.11.4077.4077
https://doi.org/10.1182/blood.v104.11.4077.4077